Código QR (código de barras bidimensional)

Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes

Abstract Introduction Respiratory syncytial virus (RSV) leads to significant morbidity in newborn infants in the United Kingdom (UK). Nirsevimab, a long-acting monoclonal antibody, received approval from the European Medicines Agency and has been licensed by the Medicines and Healthcare products Reg...

ver descrição completa

Na minha lista:
Principais autores: Alexia Kieffer, Matthieu Beuvelet, Gerald Moncayo, Mersha Chetty, Aditya Sardesai, Robert Musci, Richard Hudson
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2024-09-01
coleção:Infectious Diseases and Therapy
Assuntos:
Economics
Cost-effectiveness
Model
Lower respiratory tract disease
Nirsevimab
RSV
Acesso em linha:https://doi.org/10.1007/s40121-024-01037-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados